EStradiol and PRogesterone in In vitro ferTilization (ESPRIT): a multicenter study evaluating third- versus second-generation estradiol and progesterone immunoassays.

Autor: Polyzos NP; Department of Reproductive Medicine, Dexeus University Hospital, Gran Via Carles, 11171-75, 08028, Barcelona, Spain. nikpol@dexeus.com.; Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel, Laarbeeklaan 101, 1090, Brussels, Belgium. nikpol@dexeus.com.; Department of Clinical Medicine, Faculty of Health, Aarhus University Incuba/Skejby, Building 2, Palle Juul-Jensens Boulevard 82, Aarhus N, 8200, Aarhus, Denmark. nikpol@dexeus.com., Anckaert E; Laboratory of Hormonology and Tumour Markers, Universitair Ziekenhuis Brussel, Free University of Brussels, Brussels, Belgium., Drakopoulos P; Centre for Reproductive Medicine, University Hospital (UZB), Laarbeeklaan 101, 1090, Jette, Brussels, Belgium., Tournaye H; Centre for Reproductive Medicine, University Hospital (UZB), Laarbeeklaan 101, 1090, Jette, Brussels, Belgium., Schiettecatte J; Laboratory of Hormonology and Tumour Markers, Universitair Ziekenhuis Brussel, Free University of Brussels, Brussels, Belgium., Donner H; Medical and Scientific Affairs, Roche Diagnostics GmbH, Nonnenwald 2, 82377, Penzberg, Germany., Bobba G; Medical and Scientific Affairs, Roche Diagnostics International Ltd, Forrenstrasse 2, 6343, Rotkreuz, Switzerland., Miles G; Biostatistics and Data Management, Roche Diagnostics Operations Inc., 9115 Hague Road, Building R, Indianapolis, IN, 46256, USA., Verhagen-Kamerbeek WDJ; Medical and Scientific Affairs, Roche Diagnostics International Ltd, Forrenstrasse 2, 6343, Rotkreuz, Switzerland., Bosch E; Human Reproduction Unit, IVI-RMA, Plaza de la Policia Local 3, 46015, Valencia, Spain.

Publikováno v: Journal of endocrinological investigation [J Endocrinol Invest] 2020 Sep; Vol. 43 (9), pp. 1239-1248. Date of Electronic Publication: 2020 Mar 13.

Short-Term Prediction of Adverse Outcomes Using the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor) Ratio in Asian Women With Suspected Preeclampsia.

Autor: Bian X; From the Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Beijing, China (X.B.)., Biswas A; Department of Obstetrics and Gynecology, Yong Loo Lin School of Medicine, National University Health System, National University of Singapore, Singapore (A.B.)., Huang X; Department of Obstetrics and Gynecology, The Second Hospital of Hebei Medical University, Shijiazhuang, China (X.H.)., Lee KJ; Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University, Seoul, South Korea (K.J.L.)., Li TK; Department of Obstetrics and Gynecology, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China (T.K.-T.L.)., Masuyama H; Department of Obstetrics and Gynecology, Okayama University Hospital, Okayama, Japan (H.M.)., Ohkuchi A; Jichi Medical University Hospital, Tochigi, Japan (A.O.)., Park JS; Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, South Korea (J.S.P.)., Saito S; University of Toyama, Toyama, Japan (S.S.)., Tan KH; Department of Obstetrics and Gynecology, KK Women's and Children's Hospital, Singapore (K.H.T., K.K.H.)., Yamamoto T; Department of Obstetrics and Gynecology, Nihon University Itabashi Hospital, Tokyo, Japan (T.Y.)., Dietl A; Roche Diagnostics GmbH, Penzberg, Germany (A.D., S.G.)., Grill S; Roche Diagnostics GmbH, Penzberg, Germany (A.D., S.G.)., Verhagen-Kamerbeek WDJ; Roche Diagnostics International Ltd, Rotkreuz, Switzerland (W.D.J.V.-K, M.H.)., Shim JY; Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea (J.-Y.S.)., Hund M; Roche Diagnostics International Ltd, Rotkreuz, Switzerland (W.D.J.V.-K, M.H.).

Publikováno v: Hypertension (Dallas, Tex. : 1979) [Hypertension] 2019 Jul; Vol. 74 (1), pp. 164-172. Date of Electronic Publication: 2019 Jun 12.

Serum Anti-Müllerian Hormone Is Significantly Altered by Downregulation With Daily Gonadotropin-Releasing Hormone Agonist: A Prospective Cohort Study.

Autor: Drakopoulos P; Centre for Reproductive Medicine, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium.; Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel, Brussels, Belgium., van de Vijver A; Centre for Reproductive Medicine, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium., Parra J; CleanicData, Leuven, Belgium., Anckaert E; Centre for Reproductive Medicine, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium., Schiettecatte J; Centre for Reproductive Medicine, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium., Blockeel C; Centre for Reproductive Medicine, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium., Hund M; Roche Diagnostics International Ltd., Risch-Rotkreuz, Switzerland., Verhagen-Kamerbeek WDJ; Roche Diagnostics International Ltd., Risch-Rotkreuz, Switzerland., He Y; Roche Diagnostics GmbH, Penzberg, Germany., Tournaye H; Centre for Reproductive Medicine, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium., Polyzos NP; Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel, Brussels, Belgium.; Department of Reproductive Medicine, Dexeus University Hospital, Barcelona, Spain.; Department of Clinical Medicine, Faculty of Health, Aarhus University Incuba, Aarhus, Denmark.

Publikováno v: Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2019 Feb 26; Vol. 10, pp. 115. Date of Electronic Publication: 2019 Feb 26 (Print Publication: 2019).